Injection Rate Impact on Long-acting Injectable Depot Dissolution in Ex Vivo Porcine Tissue

Comparing the performance attributes of an on-body injector and autoinjectors

4K microstructure render of a DigiM pharmaceutical sample showing internal phase composition at high resolution
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

Understanding the impact of device injection rate on depot release kinetics

In collaboration with our partners from Gilead, this project examined how different injection rates affect the depot morphology and release kinetics of a high viscocity formulation. Of particular interest was the comparison of an on-body injection (OBI) system for self admistration with traditional injectors, including a slow auto-injector (AI), a fast auto-injector, and a fast universal tester (UT).

DigiM and Gilead case study image showing long-acting injectable depot morphology and device comparison

To assess this, X-ray micro-CT was used image ex vivo porcine tissue containing depots injected with each device. Through digital analysis, critical depot properties including volume, surface area, size, roundness, and tissue localization were measured. Finally, image-based release prediction was used to predict drug release profiles directly from the digitized depots' real morphology and shape attributes.

Image-based in vitro drug release simulations from DigiM and Gilead long-acting injectable case study

The study found significant differences across each device, the OBI producing a rounder depot, while traditional injectors tended to be flatter. A rank order difference in surace area to volume raito was also identified. For some devices, the depot was found to intrude into the intramuscular space, suggesting device type may impect permeation of the depot and localization into unpreferential tissue layers. Through the predicted release profiles, the depot from the OBI injection was found to have siginificantly longer release. Depots from slow AI, fast AI, and fast UT had faster release, following a rank order with good correspondance to their surface area to volume ratios.

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Our Expertise

In Numbers

95
+
%

Programs Supported

981
+
%

Formulations Digitized

22
+
%

Pharmaceutical Partners

Stats section background image for DigiM Solution website showing pharmaceutical data visualization context

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration